BRIEF-Imprimis Pharma Says Provided Notice Of Termination To Cantor Fitzgerald Of Controlled Equity Offering Sales Agreement

2018-11-06 20:29

Imprimis製藥(IMMY) 0

Nov 6 (Reuters) - Imprimis Pharmaceuticals Inc :
   * IMPRIMIS PHARMA - PROVIDED NOTICE OF TERMINATION TO CANTOR FITZGERALD OF CONTROLLED EQUITY OFFERING (SM) SALES AGREEMENT, DATED NOVEMBER 27, 2015
   * IMPRIMIS PHARMACEUTICALS INC - TERMINATION WILL BECOME EFFECTIVE ON NOVEMBER 15, 2018
   * IMPRIMIS - TERMINATING AGREEMENT AS CO ESTIMATES CASH FLOW PROVIDED BY OPERATIONS WILL BE SUFFICIENT TO FUND REQUIREMENTS FOR AT LEAST NEXT 12 MONTHS

Source text for Eikon: () Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

BRIEF-Imprimis Pharma Says Provided Notice Of Termination To Cantor Fitzgerald Of Controlled Equity Offering Sales Agreement

推薦文章

港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%

一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報

一周IPO | 賺錢效應持續火熱！年內24只上市新股「0」破發；「圖模融合第一股」海致科技首日飆漲逾242%

從軟件到房地產，美國多板塊陷入AI恐慌拋售潮

Meta計劃為智能眼鏡添加人臉識別技術

危機四伏，市場卻似乎毫不在意

美股機會日報 | 降息預期升溫！美國1月CPI年率創去年5月來新低；淨利、指引雙超預期！應用材料盤前漲超10%

財報前瞻 | 英偉達Q4財報放榜在即！高盛、瑞銀預計將大超預期，兩大關鍵催化將帶來意外驚喜？